# Cochrane

# Trusted evidence.

# Informed decisions.

# Library

# Better health.

# Analysis 2.2. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 2: Maintenance of clinical remission in UC: sensitivity analysis using fixed-effect model

|Study or Subgroup|Events|Total|Events|Total|Weight|M-H, Fixed, 95% CI|Risk of Bias| |
|---|---|---|---|---|---|---|---|---|
|Haifer 2022|4|4|0|6|2.0%|12.60 [0.86 , 185.05]|+ + + + + + +| |
| |Sood 2019a (1)|27|31|20|30|98.0%|1.31 [0.98 , 1.74]|+ ? + + + + +|
| |Total (95% CI)|35| |36|100.0%|1.53 [1.13 , 2.07]| | |

Total events: 31 / 20

Heterogeneity: Chi² = 3.56, df = 1 (P = 0.06); I² = 72%

Test for overall effect: Z = 2.77 (P = 0.006)

Favors FMT Favors control

Test for subgroup differences: Not applicable

# Footnotes

(1) Mayo score ≤ 2 with all subscores ≤ 1 at week 48.

# Risk of bias legend

(A) Random sequence generation (selection bias)

(B) Allocation concealment (selection bias)

(C) Blinding of participants and personnel (performance bias)

(D) Blinding of outcome assessment (detection bias)

(E) Incomplete outcome data (attrition bias)

(F) Selective reporting (reporting bias)

(G) Other bias

# Analysis 2.3. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 3: Maintenance of clinical remission in UC: sensitivity analysis for available cases

|Study or Subgroup|Events|Total|Events|Total|Weight|M-H, Random, 95% CI|M-H, Random, 95% CI|
|---|---|---|---|---|---|---|---|
|Haifer 2022|4|4|0|2|18.8%|5.40 [0.42 , 68.96]| |
|Sood 2019a|27|30|20|28|81.2%|1.26 [0.97 , 1.64]| |
|Total (95% CI)|34| |30|100.0%|1.66 [0.47 , 5.81]| | |

Total events: 31 / 20

Heterogeneity: Tau² = 0.49; Chi² = 1.57, df = 1 (P = 0.21); I² = 36%

Test for overall effect: Z = 0.79 (P = 0.43)

Favors control Favors FMT

Test for subgroup differences: Not applicable

# Analysis 2.4. Comparison 2: Fecal microbiota transplantation (FMT) versus control for maintenance of remission in ulcerative colitis (UC), Outcome 4: Serious adverse events for maintenance of remission in UC

|Study or Subgroup|Events|Total|Events|Total|Weight|M-H, Random, 95% CI|M-H, Random, 95% CI|
|---|---|---|---|---|---|---|---|
|Haifer 2022|0|4|0|6| |Not estimable| |
|Sood 2019a|0|31|0|30| |Not estimable| |
|Total (95% CI)|0| |0| | |Not estimable| |

Total events: 0 / 0

Heterogeneity: Not applicable

Test for overall effect: Not applicable

Favors control Favors FMT

Test for subgroup differences: Not applicable

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.